Published in Biochemistry on April 06, 1993
Efficient pH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA. Nucleic Acids Res (1995) 2.07
High throughput measurement of duplex, triplex and quadruplex melting curves using molecular beacons and a LightCycler. Nucleic Acids Res (2002) 1.56
Site-specific targeting of psoralen photoadducts with a triple helix-forming oligonucleotide: characterization of psoralen monoadduct and crosslink formation. Nucleic Acids Res (1994) 1.09
Polyamine-linked oligonucleotides for DNA triple helix formation. Nucleic Acids Res (1993) 1.01
Effect of third strand composition on the triple helix formation: purine versus pyrimidine oligodeoxynucleotides. Nucleic Acids Res (1996) 0.96
Triplex formation at physiological pH: comparative studies on DNA triplexes containing 5-Me-dC tethered at N4 with spermine and tetraethyleneoxyamine. Nucleic Acids Res (1997) 0.91
Triplex formation at physiological pH by 5-Me-dC-N4-(spermine) [X] oligodeoxynucleotides: non protonation of N3 in X of X*G:C triad and effect of base mismatch/ionic strength on triplex stabilities. Nucleic Acids Res (1996) 0.90
Efficient triple helix formation by oligodeoxyribonucleotides containing alpha- or beta-2-amino-5-(2-deoxy-D-ribofuranosyl) pyridine residues. Nucleic Acids Res (1996) 0.90
Relative stability of triplexes containing different numbers of T.AT and C+.GC triplets. Nucleic Acids Res (1997) 0.89
Recognition of GC base pairs by triplex forming oligonucleotides containing nucleosides derived from 2-aminopyridine. Nucleic Acids Res (1997) 0.88
Triple helix formation with purine-rich phosphorothioate-containing oligonucleotides covalently linked to an acridine derivative. Nucleic Acids Res (1997) 0.87
Use of a pyrimidine nucleoside that functions as a bidentate hydrogen bond donor for the recognition of isolated or contiguous G-C base pairs by oligonucleotide-directed triplex formation. Nucleic Acids Res (1996) 0.86
Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine. Nucleic Acids Res (1996) 0.83
Sequence composition effects on the stabilities of triple helix formation by oligonucleotides containing N7-deoxyguanosine. Nucleic Acids Res (1996) 0.80
Single strand targeted triplex formation: targeting purine-pyrimidine mixed sequences using abasic linkers. Nucleic Acids Res (1995) 0.79
Effect of DNA target sequence on triplex formation by oligo-2'-deoxy- and 2'-O-methylribonucleotides. Nucleic Acids Res (2003) 0.78
Monitoring denaturation behaviour and comparative stability of DNA triple helices using oligonucleotide-gold nanoparticle conjugates. Nucleic Acids Res (2004) 0.77
A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides. Science (1987) 14.05
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett (1998) 2.61
Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res (1996) 1.47
Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol Pharmacol (1994) 1.30
Oxazolidinones mechanism of action: inhibition of the first peptide bond formation. J Biol Chem (2001) 0.90
Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides. Mol Pharmacol (1995) 0.90
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines. J Med Chem (1999) 0.84
4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists. Bioorg Med Chem Lett (1999) 0.81
Cytotoxicity of synthetic racemic ptilocaulin: a novel cyclic guanidine. Invest New Drugs (1989) 0.80
Detection of single base differences using biotinylated nucleotides with very long linker arms. Nucleic Acids Res (1992) 0.78
Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines. J Med Chem (1999) 0.75